Potential clinical utility of MUC5B and TOLLIP single nucleotide polymorphisms (SNP) in in the management of patients with IPF.
F. Bonella (Essen, Germany), I. Campo (Pavia, Italy), E. Boerner (Essen, Germany), D. Theegarten (Essen, Germany), J. Guzman (Bochum, Germany), U. Costabel (Essen, Germany)
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Session: Translational aspects of idiopathic pulmonary fibrosis
Session type: Poster Discussion
Number: 5370
Disease area: Interstitial lung diseases
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Bonella (Essen, Germany), I. Campo (Pavia, Italy), E. Boerner (Essen, Germany), D. Theegarten (Essen, Germany), J. Guzman (Bochum, Germany), U. Costabel (Essen, Germany). Potential clinical utility of MUC5B and TOLLIP single nucleotide polymorphisms (SNP) in in the management of patients with IPF.. 5370
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: